Are International Markets Worth Investing In for U.S. Investors?

The article argues U.S. investors should allocate 5% of portfolios to the Vanguard Total International Stock ETF (VXUS) as a geographic diversifier, citing the S&P 500's 305% total return over the past decade and elevated U.S. valuations. It highlights a low 0.05% expense ratio and top holdings including Taiwan Semiconductor, Samsung Electronics, and ASML. The piece is primarily strategic commentary rather than a market-moving catalyst.

Analysis

The key market implication is not that international equities are suddenly cheap, but that the U.S. exceptionalism trade is becoming more crowded at the index level. When a small set of mega-cap U.S. names dominates returns, the marginal buyer of global diversification is really buying a hedge against concentration, valuation compression, and policy/regulatory dispersion rather than a pure growth trade. That makes the opportunity more about portfolio construction than outright alpha in non-U.S. equities.

Within VXUS, the hidden beneficiaries are the high-quality global tech supply chain names already embedded in the top holdings. TSM and ASML are levered to secular AI capex regardless of domicile, while also offering some valuation relief versus U.S. AI proxies; the second-order effect is that capital may rotate into these “global picks-and-shovels” as investors seek AI exposure with less U.S. multiple risk. BRK.B is a useful read-through because it captures the market’s current preference for balance-sheet resilience and geographic optionality over long-duration growth narratives.

The contrarian risk is that international allocation is often a slow-burn trade: it needs either a drawdown in U.S. multiples or a sustained improvement in ex-U.S. earnings revisions to work, which can take quarters. If the dollar strengthens on relative growth or rates stay higher-for-longer, VXUS can underperform even with decent local-currency returns. So the trade is less about calling a top in the U.S. and more about paying a modest premium for a diversification hedge before the crowd gets there.

For catalysts, watch whether AI capex broadens beyond the U.S. megacaps into Taiwan/Korea/Europe equipment and foundry demand over the next 6-12 months. If that happens, VXUS can outperform with far less headline multiple expansion than U.S. equities, because earnings mix improves before sentiment does. The right framing is not 'buy international because it is cheap' but 'own selective ex-U.S. beneficiaries where fundamentals are already de-risking the geographic rebalancing theme.'

Key Decisions for Investors

• Add a 3-5% strategic position in VXUS over the next 2-4 weeks as a portfolio hedge against U.S. mega-cap concentration; use it as a diversification sleeve, not a standalone return driver.
• For a more efficient expression, go long TSM and ASML vs. a U.S. large-cap growth basket over 6-12 months; the setup favors the non-U.S. AI supply chain if global capex broadens and U.S. multiples compress.
• Use BRK.B as a defensive equity ballast in the same book: long BRK.B / short an equal-dollar basket of high-duration U.S. mega-cap tech for a 3-6 month relative-value trade if rates remain sticky and breadth stays narrow.
• If the dollar rallies materially over the next 1-3 months, fade the immediate upside in VXUS and wait for a better entry; currency can swamp local equity performance in the near term.
• If ex-U.S. earnings revisions inflect positive for 2 consecutive months, add to VXUS and rotate out of lower-quality U.S. cyclicals; that would signal the trade is transitioning from valuation hedge to fundamentals-driven outperformance.